In This Section      

Johns Hopkins Medicine Suburban - FDA Authorizes New Stem Cell Trial at Suburban Hospital

New Directions Summer 2012

FDA Authorizes New Stem Cell Trial at Suburban Hospital

Date: June 1, 2012

In conjunction with the NIH’s Center for Regenerative Medicine, the NIH Heart Center at Suburban Hospital is actively recruiting patients with severe coronary artery disease and reduced heart pumping function for enrollment in an exciting clinical trial.  Participants undergoing coronary artery bypass grafting (CABG) or TMR (transmyocardial laser revascularization) will have stem cells harvested from their own hip bones and injected into their heart muscle. 

Earlier tests in animals with damaged heart muscle have shown that injecting stem cells can improve the heart’s functioning.  “By using the patient’s own cells, there is no chance of rejection and these cells should improve the blood flow to the heart and aid repair of damaged heart muscle,” says Dr. Keith Horvath, chief of Cardiothoracic Surgery at Suburban Hospital and director of the Cardiothoracic Surgery Research Program at the National Heart, Lung, and Blood Institute. 

To determine if you are a candidate for this study, please call the NIH Heart Center at 301-896-7610.